Bounded sets in topological groups and embeddings

We show that the existence of a non-metrizable compact subspace of a topological group G often implies that G contains an uncountable supersequence (a copy of the one-point compactification of an uncountable discrete space). The existence of uncountable supersequences in a topological group has a strong impact on bounded subsets of the group. For example, if a topological group G contains an uncountable supersequence and K is a closed bounded subset of G which does not contain uncountable supersequences, then any subset A of K is bounded in G?(K?A). We also show that every precompact Abelian topological group H can be embedded as a closed subgroup into a precompact Abelian topological group G such that H is bounded in G and all bounded subsets of the quotient group G/H are finite. This complements Ursul's result on closed embeddings of precompact groups to pseudocompact groups.     

On the effect of montmorillonite in the curing reaction of epoxy nanocomposites

The procedure for the fabrication of epoxy-based polymer layered silicate nanocomposites is important in respect of the nanostructure that is developed. To further our understanding of this, the influence of an organically modified clay (montmorillonite, MMT) on the curing kinetics of an epoxy resin has been studied by differential scanning calorimetry. Clay loadings of 10 and 20 mass% are used, and isothermal as well as dynamic cures have been investigated. For both cure schedules the effect of the MMT is to advance the reaction. Kinetic analysis yields values for the activation energy, but shows that the reaction cannot be described simply by the usual autocatalytic equation. The glass transition of the cured nanocomposites is lower than that for the cured neat resin, a result that is attributed to homopolymerisation taking place in addition to the epoxy–amine reaction.     

Crystal structure oftrans-ethyl(1,5,6-trimethylbenzimidazole)-bis(dimethylglyoximato)cobalt(III). Relationships between structural and spectroscopic properties in compounds of the general formulae [Co(dmgH)2(R)(1,5,6-Me3Bzm)]

Summary The synthesis and x-ray crystal structure oftrans-[Co(dmgH)₂(Et)(1,5,6-Me₃Bzm)] where dmgH=dimethylglyoximate(–1), and 1,5,6-Me₃Bzm=1,5,6-trimethylbenzimidazole, is reported. The compound C₁₉H₂₆N₆O₄Co is monoclinic, space group P2₁/n;a=11.700(4);b=24.205(6);c=8.500(3) Å and =101.63(3)°. D(calcd) 1.299 g cm^–3; Z=4 and R=0.066 for 2359 independent reflections. Comparison of Co-N(axial ligand) bond lengths for compounds of general formulaetrans-[Co(dmgH)₂(R)(L)], with L=pyridine or 1,5,6-trimethylbenzimidazole and R=CH(CN)Cl, CH₂NO₂, Me, Et,i-Pr, cyclo-hexyl or adamantyl is made. The Co–N(1,5,6-Me₃Bzm) bond lengths of the trimethylbenzimidazole derivatives show a fairly linear relationship with the electronic parameter of the axial R group, derived from the¹³C-n.m.r. spectra of their pyridine analogues. The influence of steric effects on the properties of these Co^III compounds is discussed.     

Synthesis and Characterization of Heterodinuclear IrCo, RuCo, IrNi, and RuNi Complexes Containing Pyrazolate and Pyrazolylborate Ligands

Treatment of the metallo ligands [ML(pz)(2)(Hpz)] (pz = pyrazolate; L = C(5)Me(5), M = Ir (1); L = mesitylene, M = Ru (3)) with [M'Cl{HB(3-i-Pr-4-Br-pz)(3)}] (M' = Co (4), Ni (5)) yields heterodinuclear complexes of formula [LM(&mgr;-pz)(2)(&mgr;-Cl)M'{HB(3-i-Pr-4-Br-pz)(3)}] (L = C(5)Me(5); M = Ir; M' = Co (6), Ni (7). L = mesitylene; M = Ru; M' = Co (8)). The related complex [Ru(eta(6)-p-cymene)(pz)(2)(Hpz)] (2) reacts with equimolar amounts of 4 or 5 to give mixtures of the corresponding bis(&mgr;-pyrazolato) &mgr;-chloro complexes [(eta(6)-p-cymene)Ru(&mgr;-pz)(2)(&mgr;-Cl)M'{HB(3-i-Pr-4-Br-pz)(3)}] (M' = Co (9), Ni (10)) and the triply pyrazolato-bridged complexes [(eta(6)-p-cymene)Ru(&mgr;-pz)(3)M'{HB(3-i-Pr-4-Br-pz)(3)}] (M' = Co (11), Ni (12)). Complex 1 reacts with 5 in the presence of KOH to give the IrNi complex [(eta(5)-C(5)Me(5))Ir(&mgr;-pz)(3)Ni{HB(3-i-Pr-4-Br-pz)(3)}] (13) whereas its reaction with 4 and KOH rendered the bis(&mgr;-pyrazolato) &mgr;-hydroxo complex [(eta(5)-C(5)Me(5))Ir(&mgr;-pz)(2)(&mgr;-OH)Co{HB(3-i-Pr-4-Br-pz)(3)}] (14). The molecular structure of the heterobridged IrCo complex (6) and those of the homobridged RuNi (12) and IrNi (13) complexes have been determined by X-ray analyses. Compound 6 crystallizes in the monoclinic space group P2(1)/n, with a = 10.146(5) ?, b = 18.435(4) ?, c = 22.187(13) ?, beta = 97.28(4) degrees, and Z = 4. Complex 12 is monoclinic, space group P2(1), with a = 10.1169(7) ?, b = 21.692(2) ?, c = 11.419(1) ?, beta = 112.179(7) degrees, and Z = 2. Compound 13 crystallizes in the monoclinic space group Cc, with a = 13.695(2) ?, b = 27.929(6) ?, c = 13.329(2) ?, beta = 94.11(4) degrees, and Z = 4. All the neutral complexes 6, 12, and 13 consist of linear M.M'.B backbones with two (6) or three (12, 13) pyrazolate ligands bridging the dimetallic M.M' units and three substituted 3-i-Pr-4-Br-pz groups joining M' to the boron atoms. The presence in the proximity of the first-row metal M' of the three space-demanding isopropyl substituents of the pyrazolate groups induces a significant trigonal distortion of the octahedral symmetry, yielding clearly different M'-N bond distances on both sides of the ideal octahedral coordination sphere of these metals.     

New phosphite-oxazoline ligands for efficient Pd-catalyzed substitution reactions

We have designed and synthesized a new family of readily available highly modular phosphite-oxazoline ligands for the Pd-catalyzed asymmetric allylic substitution reactions. The introduction of a pi-acceptor flexible bulky biphenyl phosphite moiety in the ligand design is highly adventitious in the product outcome. Thus, this ligand series affords excellent reaction rates (TOF's up to >2400 mol.(mol.h)-1) and enantioselectivities (ee's up to >99%) and, at the same time, shows a broad scope for different substrate types.     

A comparative XAS and X-ray diffraction study of new binuclear Mn(III) complexes with catalase activity. indirect effect of the counteranion on magnetic properties

Four new binuclear Mn(III) complexes with carboxylate bridges have been synthesized: [[Mn(nn)(H(2)O)](2)(mu-ClCH(2)COO)(2)(mu-O)](ClO(4))(2) with nn = bpy (1) or phen (2) and [[Mn(bpy)(H(2)O)](2)(mu-RCOO)(2)(mu-O)](NO(3))(2) with RCOO = ClCH(2)COO (3) or CH(3)COO (4). The characterization by X-ray diffraction (1 and 3) and X-ray absorption spectroscopy (XAS) (1-4) displays the relevance of this spectroscopy to the elucidation of the structural environment of the manganese ions in this kind of compound. Magnetic susceptibility data show an antiferromagnetic coupling for all the compounds: J = -2.89 cm(-1) (for 1), -8.16 cm(-1) (for 2), -0.68 cm(-1) (for 3), and -2.34 cm(-1) (for 4). Compounds 1 and 3 have the same cation complex [[Mn(bpy)(H(2)O)](2)(mu-ClCH(2)COO)(2)(mu-O)](2+), but, while 1 shows an antiferromagnetic coupling, for 3 the magnetic interaction between Mn(III) ions is very weak. The four compounds show catalase activity, and when the reaction stopped, Mn(II) compounds with different nuclearity could be obtained: binuclear [[Mn(phen)(2)](mu-ClCH(2)COO)(2)](ClO(4))(2), trinuclear [Mn(3)(bpy)(2)(mu-ClCH(2)COO)(6)], or mononuclear complexes without carboxylate. Two Mn(II) compounds without carboxylate have been characterized by X-ray diffraction: [Mn(NO(3))(2)(bpy)(2)][Mn(NO(3))(bpy)(2)(H(2)O)]NO(3) (5) and [Mn(bpy)(3)](ClO(4))(2).0.5 C(6)H(4)-1,2-(COOEt)(2).0.5H(2)O (8).     

Ring-closing metathesis of chiral allylamines. Enantioselective synthesis of (2S,3R,4S)-3,4-dihydroxyproline

The ring-closing metathesis (RCM) of two types of unsaturated chiral allylamines III, easily available from enantiomerically enriched epoxy alcohols, has been studied. Fully protected allylamines IIIa [(1)R = CH(2)-(CH(2))(n)()-CH=CH(2); (2)R = Boc; (3)R = PMB] have been prepared from unsaturated epoxy alcohols, whereas bis-allylamines IIIb ((1)R = Ph, (2)R = allyl,(3)R = Boc or PMB) have been prepared from 2,3-epoxy-3-phenylpropanol. Both types have been subjected to RCM to provide either cyclic allylamine I or II. The synthetic potential of these intermediates has been demonstrated by the enantioselective synthesis of (2S,3R,4S)-3,4-dihydroxyproline.     

Silica-supported PtSn alloy doped with Ga, In or, Tl: Characterization and catalytic behaviour in n-hexane dehydrogenation

Silica-supported trimetallic catalysts containing Pt, Sn and a group 13 metal (PtSnM, M=Ga, In, Tl) were prepared by consecutive impregnation steps from cis-[PtCl₂(PPh₃)₂] and chloride precursors. X-ray diffraction (XRD), transmission electron microscopy (TEM), selected-area electron diffraction (ED) and energy dispersive X-ray analysis (EDX) showed large platelet-like particles of PtSn_1−xM_x phases. PtSnGa catalyst with a Pt/(Sn+Ga) molar ratio of 1.72 showed a bimodal particle distribution and a Pt phase was identified. Differences in surface structures were also revealed by the performance of catalysts in the dehydrogenation of n-hexane. For PtSnIn and PtSnTl (Pt/(Sn+M) molar ratio of about 1) the dehydrogenation was favoured. In contrast, PtSnGa catalyst yielded hydrogenolysis products. Photoelectron spectra showed the Pt 4f_7/2 level at a binding energy of 70.0–71.8 eV in all cases. Moreover, the FT-IR spectra of chemisorbed CO on the PtSnGa showed a slight shift in the ν(CO) toward higher values with respect to the monometallic catalyst, pointing to an electronic effect in accordance with photoelectron spectroscopy.     

Modular bis(oxazoline) ligands for palladium catalyzed allylic alkylation: unprecedented conformational behaviour of a bis(oxazoline) palladium eta3-1,3-diphenylallyl complex

New families of enantiopure bis(oxazolines) with 4,5-trans (5 a-g) or 4,5-cis (6 c) stereochemistry at the individual rings have been prepared in high yield. Their eta(3)-allyl palladium complexes (8 a-g, 9 c and 10) have been used as catalytic precursors in allylic alkylation reactions with excellent enantioselectivities (up to 96 %) for the trans oxazoline derivatives, while Pd/6 c system was inactive. NMR studies on palladium eta(3)-1,3-diphenylallyl intermediates (11 a, c and e) showed the presence of syn/syn- and syn/anti-allyl isomers in solution; this resembles the first example of eta(3)-eta(1)-eta(3) isomerism in Pd allylic complexes containing bis(oxazolines) derived from malonic acid.     

Antidepressant Low Doses of Ketamine and Melatonin in Combination Produce Additive Neurogenesis in Human Olfactory Neuronal Precursors

Melatonin (MEL), an indolamine with diverse functions in the brain, has been shown to produce antidepressant-like effects, presumably through stimulating neurogenesis. We recently showed that the combination of MEL with ketamine (KET), an NMDA receptor antagonist, has robust antidepressant-like effects in mice, at doses that, by themselves, are non-effective and have no adverse effects. Here, we show that the KET/MEL combination increases neurogenesis in a clone derived from human olfactory neuronal precursors, a translational pre-clinical model for effects in the human CNS. Neurogenesis was assessed by the formation of cell clusters > 50 µm in diameter, positively stained for nestin, doublecortin, BrdU and Ki67, markers of progenitor cells, neurogenesis, and proliferation. FGF, EGF and BDNF growth factors increased the number of cell clusters in cultured, cloned ONPs. Similarly, KET or MEL increased the number of clusters in a dose-dependent manner. The KET/MEL combination further increased the formation of clusters, with a maximal effect obtained after a triple administration schedule. Our results show that the combination of KET/MEL, at subeffective doses that do not produce adverse effects, stimulate neurogenesis in human neuronal precursors. Moreover, the mechanism by which the combination elicits neurogenesis is meditated by melatonin receptors, CaM Kinase II and CaM antagonism. This could have clinical advantages for the fast treatment of depression.